AM gene silencing decreased the expression of both AM mRNA and protein, blocked cell proliferation, and increased the chemosensitivity of HO8910 ovarian cancer cells via downregulation of Bcl-2/p-ERK expressions [250]. The gene discussed is BCL2; the disease is ovarian carcinoma.